Clinical Trials

(Optical Research for Biopsy Triaging)​

DynamX Medical have recently completed a Phase 2 in-clinic trial on oesophageal cancer and colon cancer.  This trial was performed at four independent sites across the UK.  

400 patient in-clinic trial, deploying the system bedside at 4 NHS endoscopy units, enabling us to validate clinical performance and ensure seamless integration with established clinical workflows.

System usability was tested over a wide range of users including research nurses, endoscopists and health care assistants.

Initial analysis of the study data shows improved performance over the previous Phase 1 clinical trial, enabling significant reduction in the workload for pathology services and expansion of screening programmes.

  (RApid screening of buccal cells to Distinguish CAncer using Light)

DynamX Medical are working with Portsmouth NHS Trust on an Innovate UK funded programme to develop a non-invasive solution for early-stage screening and detection of lung cancer.

RADiCAL-Lung is aimed at screening and diagnosis of lung cancer, one of the most common and serious types of cancer.

Using a simple cheek swab, we are developing a reliable and non-invasive screening technique for early lung cancer detection.

RADiCAL-Lung will enable wide population screening for lung cancer, which usually has no signs or symptoms in the early stages.

© 2019 DynamX Medical is the trading name of BeamLine Diagnostics Ltd.
Registered in England & Wales Number 09504725.
Rutherford Appleton Laboratories, Building R103 Office R-103, Harwell Campus, Didcot, OX11 0QX
Icons made by Freepik from